Align Technology Inc Quick Ratio (ALGN) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Align Technology inc   (NASDAQ: ALGN)

Align Technology Inc 's Quick Ratio

ALGN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Align Technology Inc 's Cash & cash equivalent grew by 3.84 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Align Technology Inc 's Quick Ratio to 0.57, Quick Ratio remained below Align Technology inc average.

Within Medical Equipment & Supplies industry 143 other companies have achieved higher Quick Ratio than Align Technology Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 2196 to 2368.

Explain Quick Ratio?
How much Cash & cash equivalents ALGN´s has?
What are ALGN´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ALGN/financial-strength
https://api.csimarket.com/api/v1/companies/ALGN/fundamentals
https://api.csimarket.com/api/v1/companies/ALGN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
ALGN Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 37.61 %
Y / Y Cash & cash equivalent Change 13.97 %
Quick Ratio MRQ 0.57
ALGN's Total Ranking # 2368
Seq. Current Liabilities Change 0.15 %
Seq. Cash & cash equivalent Change 3.84 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 144
Healthcare Sector # 726
Overall Market # 2368


Quick Ratio Statistics
High Average Low
7.05 1.54 0.38
(Sep 30 2010)   (Jun 30 2024)




Financial Statements
Align Technology Inc 's Current Liabilities $ 2,002 Millions Visit ALGN's Balance sheet
Align Technology Inc 's Cash & cash equivalent $ 1,145 Millions Visit ALGN's Balance sheet
Source of ALGN's Sales Visit ALGN's Sales by Geography


Cumulative Align Technology Inc 's Quick Ratio

ALGN's Quick Ratio for the trailling 12 Months

ALGN Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 34.72 %
Y / Y Cash & cash equivalent TTM Growth 15.16 %
Quick Ratio TTM 0.56
Total Ranking TTM # 4034
Seq. Current Liabilities TTM Growth 7.43 %
Seq. Cash & cash equivalent TTM Growth 3.29 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2026 to $2,002.01 millions, cumulative Quick Ratio decreased to 0.56 below the Align Technology Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Align Technology Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3199 to 4034.

Explain Quick Ratio?
How much Cash & cash equivalents ALGN´s has?
What are ALGN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 902
Within the Market # 4034


trailing twelve months Quick Ratio Statistics
High Average Low
2.56 0.87 0.44
(Jun 30 2011)   (Sep 30 2024)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Edap Tms Sa  1.56 $ 56.269  Millions$ 36.070  Millions
Neuraxis Inc   1.55 $ 4.477  Millions$ 2.888  Millions
Envista Holdings Corporation  1.42 $ 1,158.800  Millions$ 816.300  Millions
Inogen Inc   1.38 $ 96.840  Millions$ 70.265  Millions
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions
Penumbra Inc  1.09 $ 254.282  Millions$ 233.810  Millions
Establishment Labs Holdings Inc   1.06 $ 75.812  Millions$ 71.611  Millions
Globus Medical Inc   1.02 $ 517.435  Millions$ 507.938  Millions
Envoy Medical Inc   0.98 $ 14.570  Millions$ 14.861  Millions
Integra Lifesciences Holdings Corp  0.95 $ 311.930  Millions$ 329.002  Millions
Myomo Inc   0.93 $ 11.946  Millions$ 12.902  Millions
Strata Critical Medical Inc   0.92 $ 41.641  Millions$ 45.118  Millions
Haemonetics Corporation  0.87 $ 260.712  Millions$ 300.838  Millions
Treace Medical Concepts Inc   0.86 $ 39.798  Millions$ 46.079  Millions
Innovage Holding Corp   0.85 $ 162.993  Millions$ 192.479  Millions
Lifestance Health Group Inc   0.84 $ 218.818  Millions$ 261.129  Millions
Neuronetics Inc   0.82 $ 22.106  Millions$ 26.856  Millions
Orthopediatrics Corp  0.80 $ 44.229  Millions$ 55.632  Millions
Livanova Plc  0.76 $ 563.467  Millions$ 740.193  Millions
West Pharmaceutical Services Inc   0.72 $ 464.100  Millions$ 644.300  Millions
Resmed Inc   0.72 $ 1,010.742  Millions$ 1,406.488  Millions
Electrocore Inc   0.69 $ 7.506  Millions$ 10.866  Millions
Sintx Technologies Inc   0.67 $ 2.005  Millions$ 3.004  Millions
Privia Health Group Inc   0.66 $ 446.283  Millions$ 674.358  Millions
Orthofix Medical Inc   0.62 $ 86.322  Millions$ 138.385  Millions
Carlisle Companies Incorporated  0.62 $ 546.700  Millions$ 880.300  Millions
Align Technology inc   0.57 $ 1,144.931  Millions$ 2,002.010  Millions
Angiodynamics Inc   0.57 $ 33.973  Millions$ 59.689  Millions

Date modified: 2026-11-05T14:33:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.